Keros Therapeutics, Inc. (KROS) SEC Filings — 2024

Filings

• Keros Therapeutics Files 8-K — 8-K · Dec 12, 2024
• Keros Therapeutics Files 8-K — 8-K · Dec 10, 2024
• Keros Therapeutics Files 8-K — 8-K · Dec 3, 2024
• Keros Therapeutics Files 8-K — 8-K · Nov 26, 2024
• Keros Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
• Keros Therapeutics Appoints New CMO, Elects Directors — 8-K · Oct 16, 2024
• Keros Therapeutics Files 8-K: Other Events — 8-K · Sep 30, 2024
• Keros Therapeutics Files 8-K — 8-K · Sep 3, 2024
• Keros Therapeutics Files 8-K — 8-K · Aug 28, 2024
• Keros Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
• Keros Therapeutics Files 8-K — 8-K · Jun 17, 2024
• Keros Therapeutics Collaborates with Bristol Myers Squibb — 8-K · Jun 4, 2024
• Keros Therapeutics Files 8-K — 8-K · Jun 3, 2024
• Keros Therapeutics Files 8-K on Security Holder Vote — 8-K · May 30, 2024
• Keros Therapeutics Files 8-K on Executive Changes and Financials — 8-K · May 28, 2024
• Keros Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
• Keros Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 17, 2024
• Keros Therapeutics Files 8-K — 8-K · Mar 14, 2024
• Keros Therapeutics Files 8-K — 8-K · Mar 6, 2024
• Keros Therapeutics Appoints New Chief Medical Officer — 8-K · Mar 5, 2024
• Keros Therapeutics Files 8-K on Financial Condition — 8-K · Feb 28, 2024
• Keros Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• FMR LLC & Abigail Johnson Maintain 12.93% Stake in Keros Therapeutics — SC 13G/A · Feb 9, 2024
• BlackRock Amends Keros Therapeutics Stake, Passive Investment — SC 13G/A · Jan 26, 2024
• Keros Therapeutics Files Routine 8-K for Other Event, Exhibits — 8-K · Jan 9, 2024
• Keros Therapeutics Files Routine 8-K on Jan 3 Event — 8-K · Jan 4, 2024
• Keros Therapeutics Files Routine 8-K on Jan 3, 2024 — 8-K · Jan 3, 2024